Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viswanath Das

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|April 25, 2015
Pathophysiologically relevant in vitro tumor models for drug screeningViswanath Das, Francesca Bruzzese, Petr Konečný, et al.
Protein Science : a Publication of the Protein Society|August 27, 2025
Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementiaAlladi Charanraj Goud, Ihor Kozlov, Patricie Skoupilová, et al.
Journal of Natural Products|February 6, 2018
Peloruside A-Induced Cell Death in Hypoxia Is p53 Dependent in HCT116 Colorectal Cancer CellsJiří Řehulka, Narendran Annadurai, Ivo Frydrych, et al.
Current Neuropharmacology|October 29, 2023
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and BeyondJenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Chemmedchem|November 2, 2023
Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase InhibitorsChandra Prakash Koraboina, Venkatanarayana Chowdary Maddipati, Narendran Annadurai, et al.
Medicinal Research Reviews|March 26, 2024
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studiesViswanath Das, John H Miller, Charanraj Goud Alladi, et al.
Biochimica Et Biophysica Acta. General Subjects|April 4, 2017
Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cellsJiří Řehulka, Narendran Annadurai, Ivo Frydrych, et al.
Bioorganic & Medicinal Chemistry|February 27, 2025
Design, synthesis, and biological evaluation of novel azaspirooxindolinone derivatives as potent inhibitors of ITK and BTK-dependent cancersGopal Mudasani, Naveen Kumar Rampeesa, Sreenivasa Reddy Anugu, et al.
RSC Advances|December 8, 2025
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitorsSudhakar Tangallapalli, Rambabu Gundla, Kalyani Paidikondala, et al.
ACS Omega|February 26, 2024
Novel 5-Substituted Oxindole Derivatives as Bruton's Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological EvaluationVani Madhuri Velavalapalli, Venkatanarayana Chowdary Maddipati, Soňa Gurská, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|April 25, 2015
Pathophysiologically relevant in vitro tumor models for drug screeningViswanath Das, Francesca Bruzzese, Petr Konečný, et al.
Protein Science : a Publication of the Protein Society|August 27, 2025
Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementiaAlladi Charanraj Goud, Ihor Kozlov, Patricie Skoupilová, et al.
Journal of Natural Products|February 6, 2018
Peloruside A-Induced Cell Death in Hypoxia Is p53 Dependent in HCT116 Colorectal Cancer CellsJiří Řehulka, Narendran Annadurai, Ivo Frydrych, et al.
Current Neuropharmacology|October 29, 2023
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and BeyondJenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Chemmedchem|November 2, 2023
Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase InhibitorsChandra Prakash Koraboina, Venkatanarayana Chowdary Maddipati, Narendran Annadurai, et al.
Medicinal Research Reviews|March 26, 2024
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studiesViswanath Das, John H Miller, Charanraj Goud Alladi, et al.
Biochimica Et Biophysica Acta. General Subjects|April 4, 2017
Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cellsJiří Řehulka, Narendran Annadurai, Ivo Frydrych, et al.
Bioorganic & Medicinal Chemistry|February 27, 2025
Design, synthesis, and biological evaluation of novel azaspirooxindolinone derivatives as potent inhibitors of ITK and BTK-dependent cancersGopal Mudasani, Naveen Kumar Rampeesa, Sreenivasa Reddy Anugu, et al.
RSC Advances|December 8, 2025
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitorsSudhakar Tangallapalli, Rambabu Gundla, Kalyani Paidikondala, et al.
ACS Omega|February 26, 2024
Novel 5-Substituted Oxindole Derivatives as Bruton's Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological EvaluationVani Madhuri Velavalapalli, Venkatanarayana Chowdary Maddipati, Soňa Gurská, et al.
Pageof 4